Press Releases
-
2025 PDA Drug Delivery Innovation Awards during the opening plenary session of the Universe of Pre-Filled Syringes and Injection Devices Conference
The Parenteral Drug Association (PDA) today announced the winners of the 2025 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2025 PDA Universe of Pre-Filled Syringes and Injection Devices conference in Vienna, Austria.
-
New Points to Consider on Materials in ATMP Manufacturing Available Now
The recently released Points to Consider No. 13: Materials in ATMP Manufacturing is a great resource to support the industry’s growing focus on ATMP / cell- and gene-therapies. -
PDA Partners with Quality Champions to Foster the Next Generation of Quality Professionals
The Parenteral Drug Association (PDA) is excited to announce a new partnership with Quality Champions for Life, a nonprofit organization dedicated to preparing students to become champions of quality products, processes, and systems. This collaboration aims to enhance the education and professional development of students worldwide, equipping them with the skills and knowledge needed to excel in the field of quality science. -
Just Released: Points To Consider No. 12: Restricted Access Barrier Systems
PDA has released its latest Technical Document, Points To Consider No. 12: Restricted Access Barrier Systems. The report can be accessed on the PDA bookstore and membership technical report portal.
-
PDA Announces Industry and Honor Class of 2024 Award Winners
-
Just Released: PDA /ANSI Standard 06-2025, Quality Culture Assessment of Quality Culture Guidance Documents, Models, and Tools
This new standard provides guidance on evaluating and understanding quality culture in the pharmaceutical/medical device industry. It identifies five key focus topics critical for establishing and maintaining a mature quality culture: Leadership Commitment Communication and Collaboration Employee Ownership and Engagement Continuous Improvement, and Technical Excellence.
-
PDA Releases Points to Consider Number 11 for Plasmids and Vectors in ATMP Production
This points to consider clarifies plasmid and viral vector categorization and control, quality by design concepts, control strategies, filtration, comparability, platform technologies and potency assays. -
Just Released: PDA/ANSI Standard 03-2025, Standard Practice for Quality Risk Management of Aseptic Processes
The PDA/ANSI Standard 03-2025, Standard Practice for Quality Risk Management of Aseptic Processes outlines a Quality Risk Management (QRM) method for assessing and controlling contamination risks in aseptic processing. -
The 2025 PDA Board of Directors: A Diverse Range of Interests and Expertise
PDA today released the names of its 2025 Board of Directors following fall elections by the membership. The sixteen directors represent pharmaceutical/biopharmaceutical businesses of all sizes and areas of competency across the United States, Europe and Asia.